Experienced in Ventricular Septal Defects

Daxin X. Zhou

180 Fenglin Rd, 
Shanghai, CN 
Experienced in Ventricular Septal Defects
180 Fenglin Rd, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Daxin Zhou practices in Shanghai, China. Mr. Zhou is rated as an Experienced expert by MediFind in the treatment of Ventricular Septal Defects. His top areas of expertise are Atrial Septal Defect (ASD), Tricuspid Regurgitation, Aortic Regurgitation, Aortic Valve Replacement, and Pacemaker Implantation.

His clinical research consists of co-authoring 158 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Ventricular Septal Defects.

Gender
Male

Locations

180 Fenglin Rd, Shanghai, 200032, China
Other Locations
180 Fenglin Road, Shanghai, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Prospective, Multi-Center, Single-Arm, Post Market Study of the MitraClip System for the Treatment of Symptomatic Mitral Regurgitation in China
A Prospective, Multi-Center, Single-Arm, Post Market Study of the MitraClip System for the Treatment of Symptomatic Mitral Regurgitation in China
Enrollment Status: Completed
Publish Date: December 15, 2025
Intervention Type: Device
Study Phase: Not Applicable
Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
Enrollment Status: Completed
Publish Date: June 02, 2022
Intervention Type: Drug
Study Drug: UT-15C
Study Phase: Phase 3
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Enrollment Status: Completed
Publish Date: February 13, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

158 Total Publications

Research progress on prediction models for pacemaker implantation after transcatheter aortic valve replacement
Research progress on prediction models for pacemaker implantation after transcatheter aortic valve replacement
Journal: Zhonghua xin xue guan bing za zhi
Published: November 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Zhou's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile